PPARA and metabolic dysfunction-associated steatotic liver disease: Because PPARα is expressed in many cell types and tissues with high fatty acid oxidation activity29–31,34, it is interesting to define in vivo the specific contribution of hepatocytic PPARα in preventing NAFLD.